arrow
R

Reiki Nishimura

Department of Breast Surgery
H指数:33
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2− metastatic breast cancer: a multicenter prospective cohort study

帕博西利(palbociclib)作为HR+/HER2−转移性乳腺癌的一线或二线治疗的真实世界数据:一项多中心前瞻性队列研究

2026-05-290
OAAI
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs

序贯二线内分泌治疗 (ETs) 对初始ETs敏感性较低的绝经后雌激素受体阳性和HER2-negative转移性乳腺癌患者的疗效

2020-05-114
OAAI